Need to keep on prime of the science and politics driving biotech at this time? Enroll to get our biotech publication in your inbox.
Hello! As ever, heaps happening within the light-speed world of biotech. The sector’s rally is gathering steam, the FDA’s AI flexibility is getting misplaced in translation, and Democrats lose a seasoned biopharma policymaker.
However I’m nonetheless reeling from that artificial biology SpudCell Matt Herper wrote about.

This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
View All Plans

